what is gip and glp-1 receptors Biology of Incretins: Glucose-dependent insulinotropic polypeptide receptor signaling

Clinical trials have yielded mixed results: several studies, including a phase II trial of NLY01, failed to meet primary endpoints for motor progression, with only modest or nonsignificant effects overall [37,38]

There was also a trend towards a significant main effect of treatment (main effect of treatment: F( 1,47 ) = 3.095, p 2 = 0.062, p = 0.085), but no other significant main effects of interactions ( p 0.342)

GIP works synergistically with GLP-1 to enhance insulin secretion and appears to have metabolic effects that support weight loss

Last reviewed: July 10, 2026 Last updated: July 10, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations